Google Life Sciences

See the following -

Digital health round-up: bioelectronics are closer than you think

Marco Ricci | Pharma Phorum | September 8, 2017

Towards the end of last year, Google’s life sciences division Verily and GlaxoSmithKline co-founded Galvani Bioelectronics to develop medicines that harness electrical signals in the body to treat chronic diseases like asthma, arthritis and even gastrointestinal diseases. At the time, the unveiling of Galvani felt like a new frontier in medicine and, though somewhat difficult to comprehend, something that could genuinely change the lives of millions of people worldwide...

Read More »

How Google Plans to Reinvent Healthcare

Cheryl Swanson | The Motley Fool | September 3, 2016

Glucose-monitoring contact lenses for diabetics, wrist computers that read diagnostic nanoparticles injected in the blood stream, implantable devices that modify electrical signals that pass along nerves, medication robots, human augmentation, human brain simulation -- the list goes on. That's not an inventory of improbable CGI effects from the latest sci-fi movie, it's a list of initiatives being tackled by Alphabet's Google Life Sciences research unit, recently rebranded Verily...

Read More »

Obama Administration Announces Key Actions to Accelerate Precision Medicine Initiative

Press Release | The White House | February 25, 2016

A year ago the President announced the launch of the Precision Medicine Initiative to accelerate a new era of medicine that delivers the right treatment at the right time to the right person, taking into account individuals’ health history, genes, environments, and lifestyles. Precision medicine is already transforming the way diseases like cancer and mental health conditions are treated. Molecular testing for cancer patients lets physicians and patients select treatments that improve chances of survival and reduce adverse effects...

Read More »

Pharma and Tech Giants Team Up to Design Devices That Can Hack Your Body’s Electrical Signals

Akshat Rathi | Nextgov | August 1, 2016

Electrical signals from the brain govern much of what goes on in the human body. Pharma and tech giants are spending big money to figure out how to hack these signals, a burgeoning field known as “bioelectronics.” GlaxoSmithKline and Verily Life Sciences, an Alphabet subsidiary, are investing more than $700 million over seven years to create a new company, Galvani Bioelectronics. The firm, 55 percent owned by GSK, will have one lab in Stevenage, U.K., and another in San Francisco...

Read More »

Verily launches clever new spoon That Compensates for Disabilities

Josh Baxt | MedCity News | December 4, 2016

People with physical disabilities face many challenges, such as difficulty eating, something many take for granted. But now Verily Life Sciences, formerly Google Life Sciences, has launched the Liftware Level, a handheld robotic device that compensates for erratic hand and arm movements, allowing people to eat without spilling. As part of the recent launch, the Huntington’s Disease Society of America (HDSA) and Teva Pharmaceuticals will be donating 1,000 Liftware Level Starter Kits to people who could benefit from the device...

Read More »